Bruno R. Bastos

A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)

Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand et al. · Clinical Cancer Research · 2021 · 90 citations · Full text

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors

Jennifer R. Diamond, Bruno R. Bastos, Ryan J. Hansen et al. · Clinical Cancer Research · 2010 · 64 citations · Full text

Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)

Jason J. Luke, Daniel J. Olson, Jacob B. Allred et al. · Clinical Cancer Research · 2019 · 56 citations · Full text

Phase I Studies of CBP501, a G2 Checkpoint Abrogator, as Monotherapy and in Combination with Cisplatin in Patients with Advanced Solid Tumors

Geoffrey I. Shapiro, Raoul Tibes, Michael S. Gordon et al. · Clinical Cancer Research · 2011 · 30 citations

SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer.

Thomas W. Flaig, Catherine M. Tangen, Siamak Daneshmand et al. · Journal of Clinical Oncology · 2019 · 30 citations

Surgical Oncology, Cancer Management, Oncology +16